Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications Ld LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Shares Traded Last Trade
  0.70 0.75% 94.40 71,657 10:19:29
Bid Price Offer Price High Price Low Price Open Price
94.00 94.50 94.60 92.30 92.30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 134.26 9.73 1.62 58.8 419
Last Trade Time Trade Type Trade Size Trade Price Currency
10:19:28 AT 121 94.40 GBX

Batm Advanced Communicat... (BVC) Latest News

More Batm Advanced Communicat... News
Batm Advanced Communicat... Investors    Batm Advanced Communicat... Takeover Rumours

Batm Advanced Communicat... (BVC) Discussions and Chat

Batm Advanced Communicat... Forums and Chat

Date Time Title Posts
22/4/202118:39Batm Advanced - A New Beginning18,427
12/6/202017:27BVC over-ramped and over-valued!120
15/4/202010:44BATM - Broadband bright future22,489
03/2/202008:05Coronavirus Investment - BATM2

Add a New Thread

Batm Advanced Communicat... (BVC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Batm Advanced Communicat... trades in real-time

Batm Advanced Communicat... (BVC) Top Chat Posts

Batm Advanced Communicat... Daily Update: Batm Advanced Communications Ld is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker BVC. The last closing price for Batm Advanced Communicat... was 93.70p.
Batm Advanced Communications Ld has a 4 week average price of 91.30p and a 12 week average price of 91.30p.
The 1 year high share price is 150.50p while the 1 year low share price is currently 50.60p.
There are currently 443,543,901 shares in issue and the average daily traded volume is 207,193 shares. The market capitalisation of Batm Advanced Communications Ld is £414,713,547.44.
paulisi: Good news - just need some details, then the share price might pick up...
doccash: I don't think Zvi would be interested and he is a major shareholder. A split into two companies is more likely. In reality the share price has done well from years of doldrums but I fully agree the potential is not understood by the market and splitting the Telco side to Nasdaq would be sensible.
picsous: Some harsh words there cumnor but not unjustified. I guess the share price is not as important as the actual progress made by the company, and perhaps even somewhat irrelevant? I recall Zwi saying "our shareholders are happy" last year, I guess he's right as far as I am concerned at least!
picsous: now look what you've done to the share price...
fse: haha nelly thats what I thought.... Share prices hardly ever follow any logical trend. We have all seen companies make huge positive announcements and the share price falls. Maybe it was priced in there ? Also the positive news caused a run up and people took profits and not in a hurry to buy back until the price settles after profit taking... who knows. Cant confirm this but I believe there could have been a major seller in Israel, Harel Insurance & Financial are shown having sold @6% of their holdings which amounted to sales 12M shares. TASE prices stabilised somewhat today and ended marginally higher. PER is around 60 which should not be demanding given the new products that they are releasing into the market place. As I say I figure they should be in the 120p to 160p that does not mean to say they swing out of that range. At current share price they look attractive and 115p would be a BUY not a SELL option for me.
wizzkid211: BATM Advanced Communications Ld Update on Sale of NGSoft March 01 2021 - 02:00AM UK Regulatory (RNS & others) TIDMBVC RNS Number : 6021Q BATM Advanced Communications Ld 01 March 2021 LEI: 213800FLQUB9J289RU66 1 March 2021 BATM Advanced Communications Limited ("BATM" or "the Group") Update on Sale of NGSoft Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer"). The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021. The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021. NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m. Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value." Enquiries:
leewain: It may be tipped but that doesn't make any difference to the share price PIs follow a company after doing their own research, I've seen IC tip this recently and it has hardly budged the share price RNS updates will move the price not some tipsters opinion.
owenski: $0.5 to $1.5m for an order at unknown margin on a near 400m M.cap company was never going to move the share price. Good to see their tech in a new vertical, but it doesn't exactly look like a fast moving sales item to me either. Share price has been weak for some time, probably in part because the heat has gone out of any rises connected with Covid. Whether 80p provides a share price floor time will tell, but the valuation here aint cheap either.
owenski: The share price was 45p until mid April In mid April they announced a ventilator contract and the share price took off eventually reaching 150p by mid August I'd suggest that the share price got overheated in a short time frame on the back of a Covid related announcement. Testing is a crowded market place and come vaccine rollout, the market is forward looking to other areas now and not Covid testing. I also don't see ventilators as a growth area. Bit of a sobering thought, if this starts deflating back to the 40's, not saying it will, but that's where it came from pre-Covid contract news. I picked up on the chart signals mid September that this was going to correct downwards. Anyways, I'm in no rush to buy. IMO
deltaham: Here's the impressive article: Profiting from 5G BATM Advanced Communications (BVC:135p), a provider of medical laboratory systems, diagnostic kits, cyber security and network solutions, has made an incredibly important announcement since I covered the interim results (‘In search of value opportunities’, 17 August 2020). It’s one that has prompted me to upgrade my run profits stance on the shares to an outright buy recommendation. That’s because the company has signed up its first tier 1 customer for the group’s NFVTime virtual networking solution. The cutting-edge technology enables network carriers to remotely deploy their own virtualised software-based networks and operates on both Arm-based and Intel-based architectures. The customer is a leading Asian telecommunications provider that serves enterprise and wholesale customers in more than 160 countries and 3,000 cities across the Americas, Asia, Europe, Middle East and Africa. It has licenced BATM’s NFVTime operating system for a minimum of three years. Analysts at house broker Shore Capital estimate that the market for virtualisation services “stretches into tens of billions of dollars” and revenue from the new tier 1 customer has “potential to scale into a multi-million dollar, recurring base over the next five years.” It’s incredibly high margin, too, with gross margin “building up from the 80 per cent range”. That’s a significantly higher margin than BATM makes on its traditional carrier Ethernet products. Moreover, expect further contract wins to be announced as other large tier 1 customers adopt the technology, given that NFV is a critical element in leveraging the benefits offered by 5G and Internet of Things. This highlights the potential for BATM’s revenue and cash flow to scale up rapidly. Not surprisingly, investors have reacted positively to the news. BATM’s share price rallied 15 per cent following the contract win taking the total return on the holding to 650 per cent since I included the shares in my 2017 Bargain Shares portfolio. I now feel that the earnings upgrade cycle I previously highlighted is poised to accelerate. I also feel that BATM is a US$1bn market capitalisation company in the making, implying a new target price of 171p. A cash profit multiple of 50 times to enterprise valuation may not seem a bargain, but given the high margin nature of BATM’s revenue streams, and the way it is monetising its patent protected IP, that multiple could drop like a stone if further NFV contracts are secured. From a technical perspective, a chart break-out above the 19-year high of 150p would confirm the next up-leg in the share price is underway. On a bid-offer spread of 134.5p to 135p, I rate BATM’s shares a buy.
Batm Advanced Communicat... share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Batm Advan..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210423 09:39:17